4.5 Article

Advanced models of human skeletal muscle differentiation, development and disease: Three- dimensional cultures, organoids and beyond

期刊

CURRENT OPINION IN CELL BIOLOGY
卷 73, 期 -, 页码 92-104

出版社

CURRENT BIOLOGY LTD
DOI: 10.1016/j.ceb.2021.06.004

关键词

Skeletal muscle; Tissue engineering; Stem cells; iPS cells; 3D cultures; Organoids; Disease modelling

资金

  1. European Research Council [759108]
  2. Francis Crick Institute
  3. Cancer Research UK
  4. UK Medical Research Council
  5. Welcome Trust [FC001002]
  6. Muscular Dystrophy UK [19GRO-PS48-0188, 17GRO-PS48-0093-1]
  7. BBSRC
  8. NIHR
  9. AFM-Telethon
  10. Duchenne Parent Project
  11. European Research Council (ERC) [759108] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

Researchers have made significant progress in creating advanced in vitro models of human skeletal muscle tissue using tissue engineering approaches to mimic the physical and biochemical components of native muscle tissue. Future directions include utilizing three-dimensional cultures such as organoids and biofabrication to develop platforms that are physiologically and clinically relevant for disease modeling and therapy development.
Advanced in vitro models of human skeletal muscle tissue are increasingly needed to model complex developmental dy-namics and disease mechanisms not recapitulated in animal models or in conventional monolayer cell cultures. There has been impressive progress towards creating such models by using tissue engineering approaches to recapitulate a range of physical and biochemical components of native human skel-etal muscle tissue. In this review, we discuss recent studies focussed on developing complex in vitro models of human skeletal muscle beyond monolayer cell cultures, involving skeletal myogenic differentiation from human primary myo-blasts or pluripotent stem cells, often in the presence of structural scaffolding support. We conclude with our outlook on the future of advanced skeletal muscle three-dimensional cul-tures (e.g. organoids and biofabrication) to produce physio-logically and clinically relevant platforms for disease modelling and therapy development in musculoskeletal and neuromus-cular disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据